Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Castoro

Showing results (51-60 of 124) with videos related to

Pageof 13
Sort By:
BMJ Open|November 1, 2016
Applied investigation of person-specific and context-specific factors on postoperative recovery and clinical outcomes of patients undergoing gastrointestinal cancer surgery: multicentre European studySheraz R Markar, Stella Mavroveli, Konstantinos V Petrides, et al.
Annals of Surgical Oncology|July 20, 2024
Impact of Thoracic Duct Resection on Long-Term Survival After Esophagectomy: Individual Patient Data Meta-analysisAlberto Aiolfi, Davide Bona, Matteo Cali, et al.
Pharmacogenetics and Genomics|August 22, 2013
ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapyEnrica Rumiato, Francesco Cavallin, Elisa Boldrin, et al.
BMC Surgery|June 3, 2014
Totally implantable venous access devices: retrospective analysis of different insertion techniques and predictors of complications in 796 devices implanted in a single institutionElisa Granziera, Marco Scarpa, Angelo Ciccarese, et al.
Oncotarget|February 11, 2016
Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRCMarco Scarpa, Melania Scarpa, Ignazio Castagliuolo, et al.
Human Pathology|January 6, 2012
Human epithelial growth factor receptor 2 (HER2) status in primary and metastatic esophagogastric junction adenocarcinomasMatteo Fassan, Kathrin Ludwig, Marco Pizzi, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|January 17, 2016
A germline predictive signature of response to platinum chemotherapy in esophageal cancerEnrica Rumiato, Elisa Boldrin, Sandro Malacrida, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 26, 2013
Complete clinical response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic oesophagus: is surgery always necessary?Carlo Castoro, Marco Scarpa, Matteo Cagol, et al.
Annals of Surgical Oncology|August 24, 2007
Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancerAlberto Ruol, Giuseppe Portale, Carlo Castoro, et al.
Human Pathology|April 27, 2013
The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesisMatteo Fassan, Marco Pizzi, Stefano Realdon, et al.
Pageof 13

Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
BMJ Open|November 1, 2016
Applied investigation of person-specific and context-specific factors on postoperative recovery and clinical outcomes of patients undergoing gastrointestinal cancer surgery: multicentre European studySheraz R Markar, Stella Mavroveli, Konstantinos V Petrides, et al.
Annals of Surgical Oncology|July 20, 2024
Impact of Thoracic Duct Resection on Long-Term Survival After Esophagectomy: Individual Patient Data Meta-analysisAlberto Aiolfi, Davide Bona, Matteo Cali, et al.
Pharmacogenetics and Genomics|August 22, 2013
ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapyEnrica Rumiato, Francesco Cavallin, Elisa Boldrin, et al.
BMC Surgery|June 3, 2014
Totally implantable venous access devices: retrospective analysis of different insertion techniques and predictors of complications in 796 devices implanted in a single institutionElisa Granziera, Marco Scarpa, Angelo Ciccarese, et al.
Oncotarget|February 11, 2016
Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRCMarco Scarpa, Melania Scarpa, Ignazio Castagliuolo, et al.
Human Pathology|January 6, 2012
Human epithelial growth factor receptor 2 (HER2) status in primary and metastatic esophagogastric junction adenocarcinomasMatteo Fassan, Kathrin Ludwig, Marco Pizzi, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|January 17, 2016
A germline predictive signature of response to platinum chemotherapy in esophageal cancerEnrica Rumiato, Elisa Boldrin, Sandro Malacrida, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 26, 2013
Complete clinical response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic oesophagus: is surgery always necessary?Carlo Castoro, Marco Scarpa, Matteo Cagol, et al.
Annals of Surgical Oncology|August 24, 2007
Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancerAlberto Ruol, Giuseppe Portale, Carlo Castoro, et al.
Human Pathology|April 27, 2013
The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesisMatteo Fassan, Marco Pizzi, Stefano Realdon, et al.
Pageof 13